WHITTIER TRUST CO - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
WHITTIER TRUST CO ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$38,309
-22.2%
1,212
+0.3%
0.00%0.0%
Q2 2023$49,248
+9.4%
1,2080.0%0.00%0.0%
Q1 2023$45,021
+6.9%
1,2080.0%0.00%0.0%
Q4 2022$42,133
-2.0%
1,208
+58.9%
0.00%0.0%
Q3 2022$43,000
+10.3%
7600.0%0.00%0.0%
Q2 2022$39,000
-29.1%
7600.0%0.00%0.0%
Q1 2022$55,000
-38.9%
7600.0%0.00%0.0%
Q4 2021$90,000
+69.8%
760
+93.4%
0.00%0.0%
Q3 2021$53,000
-17.2%
3930.0%0.00%0.0%
Q2 2021$64,000
+100.0%
3930.0%0.00%0.0%
Q1 2021$32,000
+52.4%
3930.0%0.00%
Q4 2020$21,000
+162.5%
3930.0%0.00%
Q3 2020$8,0000.0%3930.0%0.00%
Q2 2020$8,000
+60.0%
3930.0%0.00%
Q1 2020$5,000
-16.7%
3930.0%0.00%
Q4 2019$6,000
+20.0%
3930.0%0.00%
Q3 2019$5,000
-16.7%
3930.0%0.00%
Q2 2019$6,000
-14.3%
3930.0%0.00%
Q1 2019$7,000
+40.0%
3930.0%0.00%
Q4 2018$5,000
-54.5%
3930.0%0.00%
Q3 2018$11,0000.0%3930.0%0.00%
Q2 2018$11,0003930.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders